🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of the present study is comparing the effectiveness of different tr...
Status
Completed
Location
Faculty of medicine, Beni-suef univeristy - Beni-Seuf university hospital
Start Date
2019-11-01
Trial ID
NCT04301336
To evaluate the safety and efficacy profile of different treatment regimens...
Status
Terminated
Location
Multiple Locations
Start Date
2008-08-20
Trial ID
NCT00726232
Treatments Being Tested
The purpose of this phase IIb, international, multicentre, double-blind, ra...
Status
Completed
Location
Centre Suisse de Recherches Scientifiques en Côte d'Ivoire (CSRS)
Start Date
2019-05-28
Trial ID
NCT03806452
Treatments Being Tested
This is a Phase 2, multicenter, two-arm, open-label study to evaluate the s...
Status
Active Not Recruiting
Location
The Oncology Institute of Hope and Innovation
Start Date
2021-03-17
Trial ID
NCT04562870
Treatments Being Tested
To assess the safety and efficacy of galinpepimut-S (GPS) compared with inv...
Status
Active Not Recruiting
Location
O'Neal Comprehensive Cancer Center
Start Date
2021-02-08
Trial ID
NCT04229979
Treatments Being Tested
Q05105 tablet is a Janus kinase 2 (JAK2) inhibitor, which can be used to tr...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2021-11-11
Trial ID
NCT05020652
Treatments Being Tested
ICA-17043 is being developed for the chronic treatment of patients with sic...
Status
Completed
Location
Study Site
Start Date
2002-02
Trial ID
NCT00040677
Treatments Being Tested
This pilot Phase II study is designed to evaluate the efficacy and tolerabi...
Status
Completed
Location
MD Anderson Cancer Center
Start Date
2012-10
Trial ID
NCT01657682
Treatments Being Tested
This trial adopts an open, randomized, parallel controlled, multicenter cli...
Status
Recruiting
Location
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS)
Start Date
2025-09-23
Trial ID
NCT07232290
Treatments Being Tested
This is a Phase III study comparing Imatinib mesylate and hydroxyurea combi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2004-10
Trial ID
NCT00154375
Treatments Being Tested